Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-25-000283

Director sold 3,948 shares at $55.17 ($217,811)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Collins Richard Alexander Director 2025-11-10 Sale 10b5-1 −3,948 $55.17 $217,811 37,994 I: show line 1 in the form
Open-market sales · 3,948 sh · avg $55.17 · $217,811
Loading xslF345X05/wk-form4_1762819958.xml…